G.Barekat Pharm (XTEH:BRKT1) ROE % Adjusted to Book Value : 15.82% (As of Mar. 2017)

View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm ROE % Adjusted to Book Value?

G.Barekat Pharm's ROE % for the quarter that ended in Mar. 2017 was 20.88%. G.Barekat Pharm's PB Ratio for the quarter that ended in Mar. 2017 was 1.32. G.Barekat Pharm's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2017 was 15.82%.

G.Barekat Pharm ROE % Adjusted to Book Value Historical Data

The historical data trend for G.Barekat Pharm's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm ROE % Adjusted to Book Value Chart

G.Barekat Pharm Annual Data

Trend

Mar16

Mar17

ROE % Adjusted to Book Value

15.82

G.Barekat Pharm Semi-Annual Data
	Mar16	Mar17
ROE % Adjusted to Book Value	-	15.82

Competitive Comparison of G.Barekat Pharm's ROE % Adjusted to Book Value

For the Biotechnology subindustry, G.Barekat Pharm's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

G.Barekat Pharm's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, G.Barekat Pharm's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where G.Barekat Pharm's ROE % Adjusted to Book Value falls into.

G.Barekat Pharm ROE % Adjusted to Book Value Calculation

G.Barekat Pharm's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2017 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	20.88%	/	1.32
	=	15.82%

G.Barekat Pharm's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2017 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	20.88%	/	1.32
	=	15.82%

G.Barekat Pharm ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

G.Barekat Pharm (XTEH:BRKT1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN

Website

http://www.bpharmed.com

G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines